Table 1

Comparison of characteristics and clinical findings between Caucasian and non-Caucasian patients

VariableCaucasianNon-Caucasianp Value
n=62n=21
Age, median (range)58 (25–84)41 (23–68)0.001
Ophthalmological findings, n (%)
 Intraocular manifestations0.16
  Anterior8 (12.9)8 (38.1)
  Anterior intermediate9 (14.5)1 (4.8)
  Intermediate4 (6.5)1 (4.8)
  Posterior7 (11.3)2 (9.5)
  Panuveitis34 (54.8)9 (42.9)
 Chronic form47 (78.3)7 (43.8)0.01
 Bilateral involvement47 (75.8)15 (71.4)0.91
 Granulomatous uveitis34 (55.7)13 (61.9)0.81
 Elevated IOP4 (6.5)0 (0)0.57
 CME28 (46.7)4 (19.0)0.05
 PMC22 (36.7)5 (23.8)0.42
Serum markers, n (%)
 High ACE36 (59)14 (70)0.54
 Normal ACE25 (41)6 (30)
 High lysozyme level38 (82.6)14 (87.5)1
 Normal lysozyme level8 (17.4)2 (12.5)
Chest imaging, n (%)
 Abnormal chest X-rays33 (57.9)16 (76.2)0.22
 Abnormal chest CTs53 (89.8)20 (95.2)0.67
  • CME, chronic macular oedema; elevated IOP, chronically elevated intraocular pressure >21 mm Hg resulting from damage of angle; PMC, peripheral multifocal choroiditis.